All Stories

  1. Hypoglycaemic stimulation of macrophage cytokine release is suppressed by AMP‐activated protein kinase activation

    Article • Diabetic Medicine, December 2024, Wiley

    Dr Craig Beall

  2. Validation of a refined protocol for mouse oral glucose tolerance testing without gavage

    Article • September 2024, Cold Spring Harbor Laboratory Press

    Dr Craig Beall

  3. Regulation of astrocyte metabolism by mitochondrial translocator protein 18 kDa

    Article • Journal of Neurochemistry, March 2024, Wiley

    Dr Craig Beall

  4. Pharmacological AMP-activated protein kinase activation suppresses low glucose-dependent macrophage migration inhibitory factor release from macrophages

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Dr Craig Beall

  5. Regulation of astrocyte metabolism by mitochondrial translocator protein 18kDa

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Dr Craig Beall

  6. Amino acid homeostasis is a target of metformin therapy

    Article • Molecular Metabolism, August 2023, Elsevier

    Dr Craig Beall

  7. Impact of chemogenetic activation of dorsal vagal complex astrocytes in mice on adaptive glucoregulatory responses

    Article • Journal of Neuroendocrinology, June 2023, Wiley

    Dr Craig Beall

  8. Glutamate Prevents Altered Mitochondrial Function Following Recurrent Low Glucose in Hypothalamic but Not Cortical Primary Rat Astrocytes

    Article • Cells, October 2022, MDPI AG

    Dr Craig Beall

  9. Brain Permeable AMP-Activated Protein Kinase Activator R481 Raises Glycaemia by Autonomic Nervous System Activation and Amplifies the Counterregulatory Response to Hypoglycaemia in Rats

    Article • Frontiers in Endocrinology, December 2021, Frontiers

    Dr Craig Beall

  10. Astrocytes in the dorsal vagal complex are not activated by systemic glucoprivation and their chemogenetic activation does not elicit homeostatic glucoregulatory responses in mice

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Dr Craig Beall

  11. Absence of the mitochondrial translocator protein 18 kDa in mice does not affect body weight or food intake responses to altered energy availability

    Article • Journal of Neuroendocrinology, August 2021, Wiley

    Dr Craig Beall

  12. Attenuated Induction of the Unfolded Protein Response in Adult Human Primary Astrocytes in Response to Recurrent Low Glucose

    Article • Frontiers in Endocrinology, May 2021, Frontiers

    Dr Craig Beall

  13. Brain-Body Control of Glucose Homeostasis—Insights From Model Organisms

    Article • Frontiers in Endocrinology, March 2021, Frontiers

    Dr Craig Beall

  14. Extracellular ATP Increases Glucose Metabolism in Skeletal Muscle Cells in a P2 Receptor Dependent Manner but Does Not Contribute to Palmitate-Induced Insulin Resistance

    Article • Frontiers in Physiology, September 2020, Frontiers

    Dr Craig Beall

  15. Analysis of the transcriptome and DNA methylome in response to acute and recurrent low glucose in human primary astrocytes

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Dr Craig Beall

  16. The metabolic response to inflammation in astrocytes is regulated by nuclear factor‐kappa B signaling

    Article • Glia, April 2020, Wiley

    Dr Craig Beall

  17. Changes in neuronal activity across the mouse ventromedial nucleus of the hypothalamus in response to low glucose: evaluation using an extracellular multi‐electrode array approach

    Article • Journal of Neuroendocrinology, December 2019, Wiley

    Dr Craig Beall

  18. Regulation of food intake by astrocytes in the brainstem dorsal vagal complex

    Article • Glia, December 2019, Wiley

    Dr Craig Beall

  19. Immunometabolic Changes in Glia – A Potential Role in the Pathophysiology of Obesity and Diabetes

    Article • Neuroscience, November 2019, Elsevier

    Dr Craig Beall

  20. Brain permeable AMPK activator R481 raises glycemia by autonomic nervous system activation and amplifies the counterregulatory response to hypoglycemia in rats

    Article • August 2019, Cold Spring Harbor Laboratory Press

    Dr Craig Beall

  21. Astrocytes in neuroendocrine systems: An overview

    Article • Journal of Neuroendocrinology, May 2019, Wiley

    Dr Craig Beall

  22. Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes

    Article • Diabetologia, October 2018, Springer Science + Business Media

    Dr Craig Beall

  23. Regulation of hepatic glucose production and AMPK by AICAR but not by metformin depends on drug uptake through the equilibrative nucleoside transporter 1 (ENT1)

    Article • Diabetes Obesity and Metabolism, August 2018, Wiley

    Dr Craig Beall

  24. Human primary astrocytes increase basal fatty acid oxidation following recurrent low glucose to maintain intracellular nucleotide levels

    Article • February 2018, Cold Spring Harbor Laboratory Press

    Dr Craig Beall

  25. The species origin of the cellular microenvironment influences markers of beta cell fate and function in EndoC-βH1 cells

    Article • Experimental Cell Research, December 2017, Elsevier

    Dr Craig Beall

  26. CNS Targets of Adipokines

    Article • September 2017, Wiley

    Dr Craig Beall

  27. AMP-activated protein kinase (AMPK) activator A-769662 increases intracellular calcium and ATP release from astrocytes in an AMPK-independent manner

    Article • Diabetes Obesity and Metabolism, April 2017, Wiley

    Dr Craig Beall

  28. Oleate induces K ATP channel-dependent hyperpolarization in mouse hypothalamic glucose-excited neurons without altering cellular energy charge

    Article • Neuroscience, March 2017, Elsevier

    Dr Craig Beall

  29. Chronic exposure to KATP channel openers results in attenuated glucose sensing in hypothalamic GT1-7 neurons

    Article • Neuropharmacology, December 2016, Elsevier

    Dr Craig Beall

  30. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status

    Article • Circulation Research, August 2016, Wolters Kluwer Health

    Dr Craig Beall

  31. Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function

    Article • Cell Metabolism, May 2016, Elsevier

    Dr Craig Beall

  32. Anti-inflammatory effects of metformin and their relationship to the therapeutic action of the drug

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Dr Craig Beall

  33. Characterisation of the astrocytic response to acute and recurrent hypoglycaemia

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Dr Craig Beall

  34. Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle

    Article • The Journal of Physiological Sciences, September 2013, Springer Science + Business Media

    Dr Craig Beall

  35. Continuous hypothalamic KATP activation blunts glucose counter-regulation in vivo in rats and suppresses KATP conductance in vitro

    Article • Diabetologia, June 2013, Springer Science + Business Media

    Dr Craig Beall

  36. AMPK modulates glucose-sensing in insulin-secreting cells by altered phosphotransfer to KATP channels

    Article • Journal of Bioenergetics and Biomembranes, April 2013, Springer Science + Business Media

    Dr Craig Beall

  37. Hypoglycaemia: Exercise for the Brain?

    Article • Journal of Neuroendocrinology, September 2012, Wiley

    Dr Craig Beall

  38. Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour

    Article • Diabetologia, July 2012, Springer Science + Business Media

    Dr Craig Beall

  39. The physiology and pathophysiology of the neural control of the counterregulatory response

    Article • AJP Regulatory Integrative and Comparative Physiology, January 2012, American Physiological Society

    Dr Craig Beall

  40. Loss of AMP-activated protein kinase α2 subunit in mouse β-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia

    Article • Biochemical Journal, July 2010, Portland Press Ltd.

    Dr Craig Beall